88 related articles for article (PubMed ID: 17891002)
1. Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections.
Charles S; Rosenfeld PJ; Gayer S
Retina; 2007 Sep; 27(7):813-5. PubMed ID: 17891002
[No Abstract] [Full Text] [Related]
2. Incidence of hemorrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients.
Mason JO; Frederick PA; Neimkin MG; White MF; Feist RM; Thomley ML; Albert MA
Retina; 2010 Oct; 30(9):1386-9. PubMed ID: 20924260
[TBL] [Abstract][Full Text] [Related]
3. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab (Avastin) treatment is safe in terms of intraocular and blood pressure.
Kernt M; Neubauer AS; Kampik A
Acta Ophthalmol Scand; 2007 Feb; 85(1):119-20. PubMed ID: 17244226
[No Abstract] [Full Text] [Related]
5. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage.
Cheema RA; Mushtaq J; Al-Khars W; Al-Askar E; Cheema MA
Retina; 2010; 30(10):1646-50. PubMed ID: 20634777
[TBL] [Abstract][Full Text] [Related]
6. Re: Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin).
Utman SA; Dhillon B
Retina; 2008 Apr; 28(4):667; author reply 667-8. PubMed ID: 18398378
[No Abstract] [Full Text] [Related]
7. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
[TBL] [Abstract][Full Text] [Related]
8. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
Kychenthal A; Dorta P
Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
[TBL] [Abstract][Full Text] [Related]
9. Combined intravitreal pharmacosurgery in patients with occult choroidal neovascularization secondary to wet age-related macular degeneration.
Koss MJ; Scholtz S; Haeussler-Sinangin Y; Singh P; Koch FH
Ophthalmologica; 2010; 224(2):72-8. PubMed ID: 19707030
[TBL] [Abstract][Full Text] [Related]
10. Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab.
Kubota T; Morita H; Tou N; Nitta N; Tawara A; Satoh H; Shimajiri S
Retina; 2010 Mar; 30(3):468-72. PubMed ID: 19952991
[TBL] [Abstract][Full Text] [Related]
11. Reflux after intravitreal injection of bevacizumab.
Boon CJ; Crama N; Klevering BJ; van Kuijk FJ; Hoyng CB
Ophthalmology; 2008 Jul; 115(7):1270; author reply 1271. PubMed ID: 18598829
[No Abstract] [Full Text] [Related]
12. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
[TBL] [Abstract][Full Text] [Related]
13. The effects of intravitreal ophthalmic medications on intraocular pressure.
Wu H; Chen TC
Semin Ophthalmol; 2009; 24(2):100-5. PubMed ID: 19373694
[TBL] [Abstract][Full Text] [Related]
14. Incidence of ocular hemorrhages in anticoagulated patients receiving repeated intravitreal injections.
Meyer CH; Eter N
Am J Ophthalmol; 2008 Feb; 145(2):386-7. PubMed ID: 18222195
[No Abstract] [Full Text] [Related]
15. Vitreous web after pars plana vitrectomy and bevacizumab with fluid-air exchange.
Chiang A; Reddy S; Tsui I; Hubschman JP
Semin Ophthalmol; 2011 Jan; 26(1):25-7. PubMed ID: 21275601
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the use of the speculum for intravitreal injections of anti-VEGF.
Méndez PC; Vázquez CM; Villar JO; Pazos JA
Acta Ophthalmol; 2013 May; 91(3):e244-6. PubMed ID: 23356231
[No Abstract] [Full Text] [Related]
17. Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions.
Jonas JB; Libondi T; Schlichtenbrede F; Schmidbauer M
Acta Ophthalmol; 2010 Mar; 88(2):e24-5. PubMed ID: 19493250
[No Abstract] [Full Text] [Related]
18. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Nowroozzadeh MH
Retina; 2010 Sep; 30(8):1322-3; author reply 1323. PubMed ID: 20827148
[No Abstract] [Full Text] [Related]
20. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Chhablani JK; Narayanan R
Retina; 2010 Sep; 30(8):1323-24; author reply 1324. PubMed ID: 20661171
[No Abstract] [Full Text] [Related]
[Next] [New Search]
